Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Non-Current Assets (2019 - 2025)

Historic Non-Current Assets for Kymera Therapeutics (KYMR) over the last 7 years, with Q3 2025 value amounting to $573.7 million.

  • Kymera Therapeutics' Non-Current Assets rose 2308.79% to $573.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 4679.41%. This contributed to the annual value of $467.8 million for FY2024, which is 17444.35% up from last year.
  • Per Kymera Therapeutics' latest filing, its Non-Current Assets stood at $573.7 million for Q3 2025, which was up 2308.79% from $402.7 million recorded in Q2 2025.
  • Over the past 5 years, Kymera Therapeutics' Non-Current Assets peaked at $573.7 million during Q3 2025, and registered a low of $69.6 million during Q2 2021.
  • For the 5-year period, Kymera Therapeutics' Non-Current Assets averaged around $249.1 million, with its median value being $183.7 million (2022).
  • Its Non-Current Assets has fluctuated over the past 5 years, first tumbled by 5298.89% in 2021, then surged by 17444.35% in 2024.
  • Quarter analysis of 5 years shows Kymera Therapeutics' Non-Current Assets stood at $154.6 million in 2021, then increased by 18.81% to $183.7 million in 2022, then fell by 7.23% to $170.4 million in 2023, then skyrocketed by 174.44% to $467.8 million in 2024, then rose by 22.66% to $573.7 million in 2025.
  • Its Non-Current Assets was $573.7 million in Q3 2025, compared to $402.7 million in Q2 2025 and $417.4 million in Q1 2025.